Half-dose sugammadex with neostigmine versus full-dose sugammadex for reversal of rocuronium in laparoscopic bariatric surgery

Ain-Shams Journal of Anesthesiology

Table 3 Muscle relaxant recovery profile in both groups

Variable	NS group (n = 25)	S group (n = 25)	95% CI of mean difference	P value
P.NO- 90% TOF within 5 minutes	10 (40%)	15 (60%)	-0.07,0.47	0.26^a
D. R - 90% TOF (seconds)	334.1 ± 99.8	294.1 ± 95.0	-15.4, 95.4	0.15^b
D. R-Extubation (seconds)	426.2 ± 98.5	376 ± 90.4	-3.6, 103.9	0.07^b

Data are expressed as mean and standard deviation. 95% CI: 95% confidence interval. ^aMann Whitney independent samples test, ^bindependent samples t-test. *p is significant when ˂ 0.05.
All the patients reach 90% TOF ratio before 10 minutes after reverse administration in both groups
No signs of residual blockade were documented in PACU in both groups
Abbreviations: group (NS) half dose sugammadex plus neostigmine, group (S) full dose sugammadex group. P.NO- 90% TOF within 5 minutes Number of patients reached 90% TOF within 5 minutes, D. R - 90% TOF (seconds) Duration between IV reversal and 90% TOF (seconds), D. R-Extubation, Duration between IV reversal and extubation